Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleftherios Michailidis

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Plos One|June 25, 2021
DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2Mayu O Frank, Nathalie E Blachere, Salina Parveen, et al.
Plos Biology|September 24, 2024
A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resistJérémie Le Pen, Gabrielle Paniccia, Volker Kinast, et al.
Cancer Discovery|June 15, 2021
Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient ScreeningGadi Lalazar, David Requena, Lavoisier Ramos-Espiritu, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent IndividualsDavide F Robbiani, Christian Gaebler, Frauke Muecksch, et al.
Nature|June 20, 2020
Convergent antibody responses to SARS-CoV-2 in convalescent individualsDavide F Robbiani, Christian Gaebler, Frauke Muecksch, et al.
The Journal of Experimental Medicine|February 5, 2021
Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccinePaul Bastard, Eleftherios Michailidis, Hans-Heinrich Hoffmann, et al.
Science (New York, N.Y.)|September 25, 2020
Autoantibodies against type I IFNs in patients with life-threatening COVID-19Paul Bastard, Lindsey B Rosen, Qian Zhang, et al.
Science (New York, N.Y.)|December 20, 2022
Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in childrenDanyel Lee, Jérémie Le Pen, Ahmad Yatim, et al.
Science (New York, N.Y.)|September 25, 2020
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19Qian Zhang, Paul Bastard, Zhiyong Liu, et al.
Research Square|January 19, 2022
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodiesJeremy Manry, Paul Bastard, Adrian Gervais, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Plos One|June 25, 2021
DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2Mayu O Frank, Nathalie E Blachere, Salina Parveen, et al.
Plos Biology|September 24, 2024
A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resistJérémie Le Pen, Gabrielle Paniccia, Volker Kinast, et al.
Cancer Discovery|June 15, 2021
Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient ScreeningGadi Lalazar, David Requena, Lavoisier Ramos-Espiritu, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent IndividualsDavide F Robbiani, Christian Gaebler, Frauke Muecksch, et al.
Nature|June 20, 2020
Convergent antibody responses to SARS-CoV-2 in convalescent individualsDavide F Robbiani, Christian Gaebler, Frauke Muecksch, et al.
The Journal of Experimental Medicine|February 5, 2021
Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccinePaul Bastard, Eleftherios Michailidis, Hans-Heinrich Hoffmann, et al.
Science (New York, N.Y.)|September 25, 2020
Autoantibodies against type I IFNs in patients with life-threatening COVID-19Paul Bastard, Lindsey B Rosen, Qian Zhang, et al.
Science (New York, N.Y.)|December 20, 2022
Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in childrenDanyel Lee, Jérémie Le Pen, Ahmad Yatim, et al.
Science (New York, N.Y.)|September 25, 2020
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19Qian Zhang, Paul Bastard, Zhiyong Liu, et al.
Research Square|January 19, 2022
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodiesJeremy Manry, Paul Bastard, Adrian Gervais, et al.
Pageof 8